What is Curcumin Absorb?
Curcumin Absorb is a highly bioavailable curcuminoid formulation. It contains a unique combination of three bioactive, health-promoting curcuminoids: curcumin, bisdemethoxy curcumin and demethoxy curcumin, along with turmeric oil. These three curcuminoids are the strongest, most protective and best researched constituents of the turmeric root.
Curcumin Absorb is manufactured utilizing a proprietary process which helps to optimize the absorption rate of the curcuminoids while reducing their absorption time. This process uses all-natural ingredients, including turmeric oil and vitamin E, without the use of potentially harmful surfactants.
What are the benefits of Curcumin Absorb?
Curcumin Absorb contains curcuminoids that promote a healthy inflammatory response and immune system, as well as support the body’s natural defense against bacteria.*
What is the recommended dose?
One soft gel per day is recommended.
When should I take it?
Take Curcumin Absorb with a meal.
How long can I take Curcumin Absorb for?
Curcumin Absorb is recommended for long-term use, or as directed by your practitioner.
Can it be taken with thyroid medications?
Curcumin Absorb should be taken at least 30 to 60 minutes away from thyroid medications.
Does Curcumin Absorb contain oxalates?
Some turmeric products may contain high levels of oxalates and may not be suitable for those with oxalate issues. However, Rootcology’s Curcumin Absorb does not contain significant amounts of oxalates. It contains extracts of three curcuminoids, standardized at 95%, which are low in oxalates. Any oxalates potentially present in the remaining 5% at the recommended dose, would be insignificant.
Is Curcumin Absorb soy-free?
While the vitamin E in Curcumin Absorb is derived from soy, as with most forms of vitamin E, Curcumin Absorb does not contain any soy. We complete strict testing to be sure, and there is no soy in the finished product.
I’ve heard that you need piperine in order to absorb curcumin, but I noticed that Curcumin Absorb does not contain piperine - will I be able to absorb the curcumin from this supplement?
Fortunately, we’ve been able to develop a formulation that could be an ideal alternative for those who do not tolerate piperine but still want to incorporate curcumin into their routine. Curcumin Absorb is a highly bioavailable formulation that contains a unique combination of three health-promoting curcuminoids: curcumin, bisdemethoxy curcumin and demethoxy curcumin, along with turmeric oil. The three curcuminoids are the strongest, most protective and best researched constituents of the turmeric root. Naturally occurring turmeric root powder contains only 5-7 percent curcumin, while the blend in Curcumin Absorb is concentrated to contain 95 percent curcuminoids.
Do not use if pregnant or breastfeeding, or if you have gallbladder issues, ulcers, blood thinning conditions, or GI inflammatory conditions. Do not use if you are allergic or sensitive to any of the ingredients in this supplement. Discontinue use at least two weeks prior to undergoing surgery.
DO NOT TAKE if taking the following medications: blood thinners, sulfasalazine.
Do not use if you are allergic or sensitive to any of the ingredients in this supplement.
If you are diabetic, be sure to monitor blood sugar levels while supplementing.
Discontinue use at least two weeks before undergoing surgery.
- Cho JA, Park E. Curcumin utilizes the anti-inflammatory response pathway to protect the intestine against bacterial invasion. Nutrition Research and Practice. 2015;9(2):117-122.
- García-Niño WR1, Pedraza-Chaverrí J2. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol. 2014 Jul;69:182-201
- Tan C1, Zhang L1, Cheng X1, Lin XF1, Lu RR2, Bao JD1, Yu HX3. Curcumin inhibits hypoxia-induced migration in K1 papillary thyroid cancer cells. Exp Biol Med (Maywood). 2014 Oct 27.
- Xu X1, Qin J1, Liu W2. Curcumin inhibits the invasion of thyroid cancer cells via down-regulation of PI3K/Akt signaling pathway. Gene. 2014 Aug 10;546(2):226-32.
- Shafaghati N, Hedayati M, Hosseinimehr SJ. Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells. Pharmacogn Mag. 2014 Apr;10(38):106-10
- Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol. 2007;595:425-51.
- Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25.
- Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I. Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):32-41.
- Toborek M, Kaiser S. Endothelial cell functions. Relationship to atherogenesis. Basic Res Cardiol. 1999 Oct;94(5):295-314.
- Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012 Nov;26(11):1719-25. doi: 10.1002/ptr.4639.
- Sanmukhani J, Satodia V, Trivedi J, Patel T, Tiwari D, Panchal B, et al. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytother Res. 2014 Apr;28(4):579-85. doi: 10.1002/ptr.5025.
- Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (2008) 201: 435. https://doi.org/10.1007/s00213-008-1300-y.
- Research and Science. Klaire Labs. https://klaire.com/researchandscience/. Accessed 11 August 2020.
- Tang M, Larson-Meyer D, Liebman M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. 2008;87(5):1262-1267.
- Li Y, Li M, Wu S, Tian Y. Combination of curcumin and piperine prevents formation of gallstones in C57BL6 mice fed on lithogenic diet: whether NPC1L1/SREBP2 participates in this process?. Lipids Health Dis. 2015;14(1).
- Kusuhara H, Furuie H, Inano A, et al. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br J Pharmacol. 2012;166(6):1793-1803. doi:10.1111/j.1476-5381.2012.01887.x